Sagentia Addresses ‘Solutions for Sample Preparation at Point of Care’ at AACC 2019

ANAHEIM, California, Aug. 6, 2019 /PRNewswire/ — Sagentia, the global product development and technology consultancy, today opens its booth at the 71st Annual Scientific Meeting and Clinical Lab Expo (AACC) in support of its activity in Point of Care (PoC) diagnostic systems and consumables.

The booth will showcase some of the world class products that Sagentia has helped develop and the technologies that underpin them. Visitors to the booth will have a great opportunity to find out how Sagentia has helped clients develop PoC systems enabling multi-sample testing and others to revolutionize the development of their lab testing instrumentation by driving costs down and reducing timescales.

In addition, a must-attend event is a talk being delivered by Nick Collier, Sagentia Medical CTO, and Carl Hewett, Sagentia Senior Product Developer, entitled ‘Solutions for Sample Preparation at Point of Care (PoC)’ on Tuesday 6th August, at 18:00 in the Oceanside room, Hilton, Anaheim.

“As molecular diagnostics moves to Point of Care there is much focus on how lab-based processes are being adapted to the PoC setting,” comments Nick Collier, CTO, Sagentia. “In particular, one area that is often overlooked is sample preparation. After attending the session, attendees will have an appreciation of the PoC solutions on the market, the challenges that remain to be addressed and promising technologies to keep an eye on. We also hope it will be a nice opportunity to relax and enjoy some drinks and nibbles after a busy day at AACC.”

Visit booth 2471 in Anaheim Convention Center, 6-8 August 2019, to meet some of our medical team including Nick Collier, Sagentia CTO, and Carl Hewitt, Senior Product Development Specialist. Please email us: info@sagentia.com to arrange a meeting. 

About Sagentia

Sagentia is a global science, product and technology development company. Our mission is to help companies maximize the value of their investments in R&D. We partner with clients in the medical, consumer, industrial and food & beverage sectors to help them understand the technology and market landscape, decide their future strategy, solve the complex science and technology challenges and deliver commercially successful products.

Sagentia employs over 150 scientists, engineers and market experts and is a Science Group company. Science Group provides independent advisory and leading-edge product development services focused on science and technology initiatives. It has ten offices globally, two UK-based dedicated R&D innovation centers and more than 350 employees. Other Science Group companies include OTM Consulting, Oakland Innovation, Leatherhead Food Research and TSG Consulting.

For further information visit us at: www.sagentia.com or email info@sagentia.com

www.sciencegroup.com

About AACC

At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care. From August 4-8 in Anaheim, California, the meeting’s 200-plus sessions will deliver insights on a broad range of timely healthcare topics. Highlights of these include discussions exploring direct-to-consumer genetic testing, precision medicine’s progress to date, how genes shape the brain circuitry that defines human behavior, and emerging technologies ranging from new cannabis tests to extremely rapid molecular diagnostics. 

For more information contact:

Abbie Meliniotis
Marketing Manager, Sagentia
E: abbie.meliniotis@sagentia.com
T: +44(0)1223-875570

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/sagentia-addresses-solutions-for-sample-preparation-at-point-of-care-at-aacc-2019-300897496.html

SOURCE Sagentia at AACC 2019

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

3 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

3 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

3 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

3 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

3 hours ago